PERCHLORACAP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Perchloracap, and when can generic versions of Perchloracap launch?
Perchloracap is a drug marketed by Mallinckrodt and is included in one NDA.
The generic ingredient in PERCHLORACAP is potassium perchlorate. There are two hundred and forty drug master file entries for this compound. Additional details are available on the potassium perchlorate profile page.
Summary for PERCHLORACAP
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 64 |
Patent Applications: | 1,367 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PERCHLORACAP at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PERCHLORACAP
US Patents and Regulatory Information for PERCHLORACAP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mallinckrodt | PERCHLORACAP | potassium perchlorate | CAPSULE;ORAL | 017551-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |